I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) shares fell 1.46% to $2.03 on Thursday, underperforming the broader market as the NASDAQ rose 2.78%. Despite the decline, TXMD outperformed competitor AbbVie, which dropped 2.24%. The stock remains 31.19% below its 52-week high of $2.95. Trading volume was significantly lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) slid 1.46% to $2.03 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.78% to 25,122.18 and the Dow Jones Industrial Average rising 1.19% to 52,208.06.
TherapeuticsMD Inc. closed 31.19% below its 52-week high of $2.95, which the company reached on January 27th.
Despite its losses, the stock outperformed some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 2.24% to $257.41.
Trading volume (14,081) remained 28,714 below its 50-day average volume of 42,795.
Data source: Dow Jones Market Data, FactSet. Data compiled July 30, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-30-26 1731ET